Monthly Archives: July 2011

July 26 2011 Artificial Lung Mimics Real Organ’s Design and Efficiency: Small Device Works With Air, Pure Oxygen Not Needed

ScienceDaily (July 26, 2011) — An artificial lung built by Cleveland researchers has reached efficiencies akin to the genuine organ, using air — not pure oxygen as current human-made lungs require — for the source of the essential element. Use … Continue reading

Posted in Uncategorized | Leave a comment

July 20 2011 Heartburn Treatment May Extend Survival in Idiopathic Pulmonary Fibrosis (IPF) Patients

ScienceDaily (July 20, 2011) — Patients with idiopathic pulmonary fibrosis (IPF) who report treatment for gastroespophageal reflux (GER) appear to have longer survival than IPF patients who are not treated for GERD, according to a new study from the University … Continue reading

Posted in Uncategorized | Leave a comment

July 12 2011 Bi-Partisan Congressional Coalition Reaches Across the Aisle to Introduce the Pulmonary Fibrosis Research Enhancement Act in the U.S. Congress

Landmark Legislation Will Coordinate and Expand National Research on Pulmonary Fibrosis CHICAGO, July 12, 2011 /PRNewswire-USNewswire/ — The Pulmonary Fibrosis Foundation (PFF) announced today the re-introduction of the Pulmonary Fibrosis Research Enhancement Act (PFREA). Bi-partisan Lead Sponsors, Senators Christopher Coons … Continue reading

Posted in Uncategorized | Leave a comment

July 12 2011 License Agreement for the Sale of Pirfenidone (Pirespa) in South Korea With Ildong Pharmaceutical

OSAKA, Japan, July 12, 2011 – Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) today announced that it entered into licensing agreement for the sale of pirfenidone in South Korea with ILDONG PHARMACEUTICAL … Continue reading

Posted in Uncategorized | 1 Comment

July 7 2011 InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF

BRISBANE, Calif., July 7, 2011 /PRNewswire via COMTEX/ — InterMune (NASDAQ: ITMN) today announced that patient enrollment has begun in ASCEND, a new Phase 3 study of pirfenidone for patients who suffer from idiopathic pulmonary fibrosis (IPF). ASCEND is a … Continue reading

Posted in Uncategorized | 3 Comments

July 6 2011 Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; Pulmonary Anti-Fibrotic Effect Demonstrated

TEMPE, Ariz., July 6, 2011 (GLOBE NEWSWIRE) — Capstone Therapeutics (Nasdaq:CAPS) (the “Company”) today announced results from a pre-clinical study of AZX100 in a rodent model of radiation-induced pulmonary fibrosis. Using the TUNEL assay — an established method for detecting … Continue reading

Posted in Uncategorized | Leave a comment

July 5 2011 CPF Announces Dates for National Pulmonary Fibrosis Awareness Week as Part of 10th Anniversary

PR Newswire CULVER CITY, Calif., July 5, 2011 PF Week Set for Sept. 18-24 CULVER CITY, Calif., July 5, 2011 /PRNewswire-USNewswire/ — The Coalition for Pulmonary Fibrosis (CPF) announced today it has set its 2011 National Pulmonary Fibrosis (PF) Awareness … Continue reading

Posted in Uncategorized | 2 Comments

June 30 2011 – Many More Lungs Suitable for Transplantation

ScienceDaily (June 30, 2011) — Four patients now have new lungs thanks to a purpose-built machine used for the first time worldwide by Sahlgrenska University Hospital. Acquired for research at the Sahlgrenska Academy, University of Gothenburg, Sweden, the new machine … Continue reading

Posted in Uncategorized | Leave a comment